Skip to main content
TipRanks
Go Ultimate75% OFF

Arthur Glenn Minshew Brazos Insider Profile

4 Followers

Arthur Glenn Minshew Brazos, Senior Officer at Abattis Bioceuticals, holds 585.00K shares in Abattis Bioceuticals (Ticker: ATTBF).

Arthur Glenn Minshew Brazos's Trading History

ATTBF
Abattis Bioceuticals
Jan 16, 2015Senior OfficerUninformative Buy――
ATTBF
Insider Shares: 585.00K (91.86%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jan 16, 2015Uninformative BuyC$0.00283,334C$0.00――
Dec 10, 2014Uninformative BuyC$0.0033,333C$0.00――
Nov 07, 2014Uninformative BuyC$0.0033,333C$0.00――
Oct 08, 2014Uninformative BuyC$0.0033,333C$0.00――
Sep 05, 2014Uninformative BuyC$0.0033,333C$0.00――

You May Also Like

Arthur Glenn Minshew Brazos insider profile FAQ

What is the percentage of profitable transactions made by Arthur Glenn Minshew Brazos?
The percentage of profitable transactions made by Arthur Glenn Minshew Brazos is 100%.
What is the average return per transaction made by Arthur Glenn Minshew Brazos?
The average return per transaction made by Arthur Glenn Minshew Brazos is 88.90%.
What stocks does Arthur Glenn Minshew Brazos hold?
Arthur Glenn Minshew Brazos holds: ATTBF stocks.
What was Arthur Glenn Minshew Brazos's most profitable transaction?
Arthur Glenn Minshew Brazos’s most profitable transaction was an Informative Sell of ATTBF stock on August 22, 2014. The return on the trade was 91.60%.
What is Arthur Glenn Minshew Brazos's role in Abattis Bioceuticals?
Arthur Glenn Minshew Brazos's role in Abattis Bioceuticals is Senior Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.